JZP-110: Completed Phase III enrollment

Jazz completed enrollment of about 200 patients in the double-blind, placebo-controlled Phase II 14-004 trial evaluating 75, 150 and 300 mg oral JZP-110 once daily for 4 weeks followed by a double-bli...